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Abstract Cardiac rhabdomyomas are benign cardiac tumours with few cardiac complications, but with a known
association to tuberous sclerosis that affects the neurologic outcome of the patients. We have analysed the long-term
cardiac and neurological outcomes of patients with cardiac rhabdomyomas in order to allow comprehensive prenatal
counselling, basing our findings on the records of all patients seen prenatally and postnatally with an echocardio-
graphic diagnosis of cardiac rhabdomyoma encountered from August, 1982, to September, 2007. We analysed
factors such as the number and the location of the tumours to establish their association with a diagnosis of
tuberous sclerosis, predicting the cardiac and neurologic outcomes for the patients.
Cardiac complications include arrhythmias, obstruction of the ventricular outflow tracts, and secondary
cardiogenic shock. Arrhythmias were encountered most often during the neonatal period, with supraventricular
tachycardia being the commonest rhythm disturbance identified. No specific dimension or location of the cardiac
rhabdomyomas predicted the disturbances of rhythm.
The importance of the diagnosis of tuberous sclerosis is exemplified by the neurodevelopmental complications,
with four-fifths of the patients showing epilepsy, and two-thirds having delayed development. The presence of
multiple cardiac tumours suggested a higher risk of being affected by tuberous sclerosis. The tumours generally
regress after birth, and cardiac-related problems are rare after the perinatal period. Tuberous sclerosis and the
associated neurodevelopmental complications dominate the clinical picture, and should form an important aspect of
the prenatal counselling of parents.
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A
CARDIAC RHABDOMYOMA CAN BE DIAGNOSED
prenatally, as an incidental finding in the
fetal cardiology clinic, or may be a finding in
the postnatal work-up for tuberous sclerosis. Cardiac
tumours are rare, with the incidence of the primary
tumours of the heart and pericardium, reported
from autopsy studies of patients of all ages, varying
from 0.17 to 28 in 10,000.1 In children, the most
frequent histological types are rhabdomyomas,
accounting for three-fifths of cases, with teratomas
making up one-quarter, and fibromas one-eighth.
The course during fetal life depends on the growth
and size of the tumours. Large masses can cause
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haemodynamic obstruction and subsequent cardiac
failure, as well as fetal hydrops or tachyarrhyth-
mia.2–7 While these life threatening complications
in the perinatal period are relatively rare, cardiac
complications such as disturbances of rhythm, as
well as the association with tuberous sclerosis,8
represent the crucial point for the long-term
outcome.9 Cardiac rhabdomyomas are reported to
be associated with tuberous sclerosis in up to seven-
eighths of patients,10,11 and up to four-fifths of
patients with tuberous sclerosis have cardiac
rhabdomyomas.12 The association with tuberous
sclerosis, therefore, should form an important issue
during the prenatal counselling of parents. Our
aim was to analyze the data of patients with cardiac
rhabdomyomas, establishing their long-term cardiac
and neurological outcomes in order to allow
comprehensive prenatal counselling.
Methods
This multi-center retrospective study was per-
formed using the data from all patients with an
echocardiographic diagnosis of cardiac rhabdomyoma
encountered at our institutions from August, 1982,
to September, 2007. The criteria for diagnosis
included the demonstration of the presence of
multiple intracardiac tumours with characteristic
echocardiographic appearances, in the absence of
known malignant disease, or the existence of one or
more tumours in association with tuberous sclerosis.
These criteria were based on the information
that fibromas and myxomas are invariably solitary
tumours, and on the very strong association between
rhabdomyomas and tuberous sclerosis. An addi-
tional most important criterion was the evolution of
the tumours, which is their tendency to regress and
disappear in time.
The patients with a prenatal diagnosis had been
referred for fetal echocardiography due to a suspicion
of a cardiac anomaly on obstetrical ultrasound. The
patients with postnatal diagnosis were referred either
for detection of cardiac tumours in the presence of
otherwise proven tuberous sclerosis, or were investi-
gated for cardiac symptoms such as a murmur or
disturbances of cardiac rhythm in an otherwise
healthy child.
The patients were followed up by means of
echocardiography over 3 months to 18 years, with a
mean period of 4.8 years. The age at detection, and
the number and the size of nodules at the time
of detection, were documented, together with their
evolution on follow-up echocardiography and
associated cardiac complications.
We reviewed the medical records of all patients
known to have cardiac rhabdomyoma to ascertain
the major criteria for the diagnosis of tuberous
sclerosis, evaluating findings related to the central
nervous system, the skin, renal angiomyofibromas,
and retinal harmatomas. We documented the inci-
dence of tuberous sclerosis, establishing any statistical
association with the number of tumours and their
exact cardiac location. Our hypothesis was that certain
locations were more likely to be related to tuberous
sclerosis than others. The potential association to the
number of tumours was analyzed by using Fisher’s
exact test, with results presented as p-value and Odd’s
ratio for 95% confidence intervals.
In the subgroup with precise neurological follow-
up, we documented neurodevelopmental complica-
tions in terms of the presence of epilepsy, its control,
the number of anti-epileptic drugs required, the
presence of developmental delay, requirement for
special school, and any associated behavioral issues.
The assessment of the severity of the developmental
delay as mild, moderate, or severe was based on the
developmental evaluation by paediatric neurologists.
Results
We identified 73 patients with cardiac rhabdo-
myomas. Of these patients, 20 had been diagnosed
during fetal life at a gestational age between 20 and
35 weeks, and 53 postnatally between the ages of
10 days and 11 years.
Number and location of cardiac rhabdomyomas
51 patients (70%) presented with multiple tumours,
while the remaining 22 patients had a single tumour.
In Table 1, we show the association between the
presence of multiple rhabdomyomas and the incidence
of tuberous sclerosis. There was no follow up for 4 of
the patients, and they are not included in Table 1.
Tuberous sclerosis was diagnosed in 42 of the patients
(86%) with multiple rhabdomyomas, and in 13 of the
patients (65%) with a single tumour ( p value 0.095;
Odds Ratio 3.17; confidence interval at 95% of the
odds ratio 0.79 to 12.92).
The tumours were predominantly located in the
left ventricle, with three-quarters of the patients
Table 1. Presence of multiple cardiac rhabdomyomas related to
the incidence of tuberous sclerosis.
Tuberous
sclerosis 1
Tuberous
sclerosis 2 Total
Multiple tumours 42 7 49
Single tumour 13 7 20
Total 55 14 69
Fisher’s exact test: p value 0.095; Odd’s ratio 3.17; CI at 95%
Odd’s ratio 0.79 to 12.92.
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presenting at least one tumour at this site. Almost
half of the patients had at least one tumour in the
right ventricle, just over two-fifths had a tumour in
the ventricular septum, and only a few patients had
tumours in the atrial chambers, the atrial septum,
or the pericardium.
In Table 2, we show the relation between these
different locations and the presence of tuberous
sclerosis, in other words the relative risk. The values
are given in terms of numbers of patients with and
without a diagnosis of tuberous sclerosis presenting
at least one tumour in the specific locations.
Size and evolution of cardiac rhabdomyomas
The diameter of the tumours in those diagnosed
prenatally ranged from 1 to 37 millimeters, and
from 2 to 55 millimeters in those diagnosed after
birth. In Figure 1, we show the fetal and postnatal
echocardiography of one of the patients. In those
diagnosed as positive for tuberous sclerosis, the
tumours ranged from 1 to 55 millimeters in size, as
opposed to 2 to 30 millimeters for the patients not
affected by tuberous sclerosis.
Postnatal regression in both the number and/or
size of nodules was observed for 40 of the 54
patients in whom we had follow-up echocardio-
graphic data. Complete resolution of cardiac
rhabdomyoma was documented in 28% of the
patients, and partial resolution in 46%, with 19%
showing no changes in the size of the tumours. In
4 patients, the nodules increased in size, and new
masses appeared over 6 to 14 years. Among 15
patients showing complete resolution by 6 months
to 10 years of age respectively, 12 had been
diagnosed postnatally, and 11 patients had been
diagnosed for tuberous sclerosis. In 6 patients, there
was partial resolution of big nodules, along with
Table 2. Location of the cardiac rhabdomyomas in patients with and without uberous sclerosis.
Patients with
tuberous sclerosis
Patients without
tuberous sclerosis
Relative risk
(estimated error)
Left ventricle 44 8 5.5 (0.6)
Ventricular septum 26 6 4.3 (0.6)
Right ventricle 30 3 10.0 (2.5)
Right atrium 5 1 5.0 (2.5)
Atrial septum 5 1 5.0 (2.5)
Left atrium 1 0 –
Pericardium 1 0 –
TS5 tuberous sclerosis.
Relative risk5 n(TS1)/n(TS2), estimated error for n(TS2)1 1.
Figure 1.
Fetal and postnatal cardiac rhabdomyomas. (a) Fetal echocardiogram at 35 weeks of gestation and (b) transthoracic echocardiogram at
2 weeks of age. The two 4-chamber views show a huge rhabdomyoma in the free wall of the right ventricle (arrowhead) and smaller
rhabdomyomas in the ventricular septum (stars) and in the free wall of the left ventricle (arrows). Abbreviations: A: anterior, LV: left
ventricle, RV: right ventricle, R: right.
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complete resolution of smaller nodules over a time
period of 1 to 11 years. In the remaining patients,
there was either partial resolution or no changes of
the nodules over a time period of 1 to 18 years.
Cardiac complications
Cardiac follow-up by echocardiography performed
in 54 patients showed that cardiac complications
were encountered in 22%, with 2 patients requiring
immediate intervention during the neonatal period.
The first patient diagnosed with multiple cardiac
rhabdomyoma at 34 weeks of gestational age was
delivered by elective Caesarean section at 37 weeks
due to significant obstruction of the left ventricular
outflow tract by one of the nodules, producing a
pressure gradient of almost 50mmHg by Doppler
between the aorta and the left ventricle. The nodule
was removed surgically in the neonatal period. The
second patient diagnosed with multiple cardiac
rhabdomyoma at 28 weeks gestational age was
delivered uneventfully, but had Wolf-Parkinson-
White Syndrome with refractory supraventricular
tachycardia for 3 weeks after birth requiring anti-
arrhythmic treatment, and is currently stable under
therapy. We found evidence of disturbances of rhythm
in 7 further patients, 5 in the form of occasional
paroxysmal supraventricular tachycardia with or
without Wolf-Parkinson-White syndrome in infancy.
All were stable clinically, and did not warrant any
intervention, albeit that one had ventricular arrhyth-
mia. Surgical excision of the tumour was required in
2 patients, one with sub-aortic obstruction and the
other with pulmonary obstruction. One patient died
at 22 days of age of cardiogenic shock due to
obstruction of left ventricular filling caused by a
tumour sized at 30 by 30 millimeters. There was no
specific dimension or location of the tumours that
predicted the disturbances of rhythm.
Neurodevelopmental complications
Tuberous sclerosis was a definite diagnosis in 55
patients (76%), as they fulfilled 2 or more of the major
criteria for diagnosis.13 Of these 55 cases, 20% (11)
did not have epilepsy whereas 80% (44) did (Fig. 2).
Among those with epilepsy, 32 patients had a precise
neurological follow up which showed that 2 patients
no longer require antiepileptic drugs, having had a
long seizure-free interval, 18 patients (56%) are
controlled in either good or moderate fashion, having
occasional seizures on 1 or 2 antiepileptic drugs,
and 12 patients (38%) have refractory epilepsy, still
suffering several seizures each week. In 1 patient who
had pharmaco-resistent epilepsy in infancy, seizure
surgery was performed at 14 months of age, and the
patient currently has moderately controlled epilepsy
with 2 antiepileptic drugs.
Developmental delay was seen in 36 of the
patients (68%) with tuberous sclerosis, the remain-
ing 17 patients developing normally. Findings from
follow-up were available for 25 of the patients with
developmental delay. Of these, 14 (56%) had mild
delay, 8 (32%) had moderate delay, and 3 (12%) had
severe delay. In terms of academic performance, 15
(60%) of the developmentally delayed patients are
in special schools, 5 (20%) are in regular schools
with extra support for academic work, and 5 (20%)
are young patients not yet in school. Behavioural
problems in the form of reduced attention span,
aggressiveness, hyperactivity, impatience and mood
fluctuations were encountered in 8 patients (22%)
Figure 2.
Neurodevelopmental issues in patients with tuberous sclerosis. AED – antiepileptic drugs.
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with developmental delay, one of these documented
to have autism.
Other findings
A major involvement of other organ systems not
in relation to tuberous sclerosis was noted in 2
patients, one having dysmorphism with involve-
ment of multiple organs, and the other having a
nephroblastoma requiring removal in infancy.
Discussion
As expected from previous experience,14–20 the cardiac
rhabdomyomas found in our series of patients were
benign. They showed spontaneous regression in most
cases, having appeared between 20 and 30 weeks
gestational age in any part of the heart. The main
growth of the tumours was between the second and the
third trimester, as well as during the early postnatal
period. During prenatal life, the tumours were, except
for one case, clinically silent in our series but
intrauterine death has been reported,21,22 mostly
following fetal arrhythmia and hydrops.
Among the various cardiac complications, arrhyth-
mias were the most often encountered problems23–27
during the neonatal period, with supraventricular
tachycardia being the commonest disturbance identi-
fied. Bradycardia, heart block, and pre-excitation
syndromes have also been reported.28,29 Arrhythmias
were predominantly treatable by vagal maneuver,
pharmaco-therapeutic intervention, radio-frequency
ablation and/or cardioversion. Only rarely do the
arrhythmias cause mortality. Having analyzed the size
and location of the tumours in patients with
arrhythmia compared to patients without rhythm
disturbances, we concluded that there is no specific
size or location of the tumour that can predict this
particular complication.
Further cardiac complications in our patients
included development of obstruction to intracardiac
flow, alteration of the function of the atrioventricular
valves with consequent regurgitation, cardiac dysfunc-
tion, and hydrops. Large left ventricular tumours are
known to lead to severe obstruction of the left
ventricular outflow tract in some patients, requiring
surgical excision.30,31 Very rarely, they can produce
univentricular physiology in infants, thence posing
difficult problems for management.32 The haemo-
dynamic complications encountered in late fetal life
can be minimized by well-timed induced delivery or
caesarean section. Surgery is only required for severe
haemodynamic complications, arrhythmias or other
primary cardiac tumours.33–35
As in our population, the natural history after
birth is known to be dominated by the neurological
impairment due to tuberous sclerosis.8 The impor-
tance of the diagnosis of tuberous sclerosis in a
patient presenting with cardiac rhabdomyoma is
exemplified by our findings concerning neurodeve-
lopmental complications. Of our patients with
tuberous sclerosis, four-fifths are affected by epilepsy,
and two-thirds suffer developmental delay, findings
in accordance with larger demographic series of
patients affected by tuberous sclerosis.36 Most of the
patients with epilepsy, nonetheless, are controlled in
good or moderate fashion using antiepileptic drugs,
albeit that over one-third have refractory epilepsy.
The association with tuberous sclerosis, therefore, is
an important issue during the prenatal counselling of
parents about the further neurological and psycho-
social development of their child.
On the basis of our statistical findings, and in
order to enhance the predictions for the parents
during the prenatal counseling about the risks of
developing tuberous sclerosis, we make several
suggestions, well aware that our study, although
including a reasonably large number of patients, has
all the limitations of a retrospective study.
The presence of multiple cardiac tumours in
patients suggests a risk factor of 6 to be affected by
tuberous sclerosis. This fact has already been
observed in another population,8 albeit that these
authors found a substantially higher risk factor, of
20. The risk analyses for single cardiac tumours
diverge even more. We found a risk factor of 1.9 to
be affected by tuberous sclerosis in case of a single
tumour, while the other authors8 found a factor of
0.33. This divergence could be due to a difference in
the two studied populations. We excluded all other
primary cardiac tumours than rhabdomyomas,
whereas Tworetzky et al.8 included other primary
tumours in the group of patients presenting with
single tumours. It is extremely important, therefore,
to differentiate between the primary tumours, such
as rhabdomyomas, teratomas, fibromas, and myx-
omas, during prenatal counseling, since they have a
different impact on the neurological outcome
related to tuberous sclerosis.
We also observed that the sizes of tumours in
patients affected by tuberous sclerosis are slightly
bigger. In our population, tumours with a size bigger
than 30millimetres were only observed in patients
with tuberous sclerosis. Additional research should be
performed to conclude in a more definitive way if
the size of the tumours may be a relevant factor in
the diagnosis of tuberous sclerosis. By analyzing the
incidence of cardiac rhabdomyoma at different
location related to the presence of tuberous sclerosis,
we can conclude that there is no straightforward
relationship between any of the locations and
tuberous sclerosis (Table 2). The comparison of the
22 Cardiology in the Young February 2010
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data between our patients diagnosed pre- and
postnatally shows in effect no significant difference
between the size, the cardiac complications, and the
development of tuberous sclerosis.
Tuberous sclerosis is an autosomal dominant
Mendelian condition with a large variability of
expression and 50% familial occurrence.37 We only
recently embarked on testing our patients genetically,
with so far 3 positive outcomes. This should support
the opinion that this condition should be suspected in
all children with prenatally diagnosed cardiac rhabdo-
myomas. Genetic testing, therefore, should be used in
all patients with these cardiac tumours. Prenatal
genetic analysis of the index patient and the parents to
exclude polymorphism can also be considered to
enable early implementation of further diagnostic
evaluation and genetic counselling,38 although the
sensitivity of this technique is not yet elucidated.
Recently, prenatal genetic analysis of a fetus with
cardiac rhabdomyomas has been performed to confirm
the diagnosis of tuberous sclerosis,39 albeit that precise
prenatal molecular diagnosis of tuberous sclerosis has
yet to be realized. In the absence of reliable genetic
testing, the risk-calculations should be helpful for the
prenatal counselling. Genetic testing should particu-
larly be performed for prenatal diagnosis in subsequent
pregnancies, if after having had an affected child both
parents prove negative for TSC1 and TSC2 mutations
on sequencing.
In conclusion, our study approaches a rare
problem with a potential cardiac impact perinatally
and in early infancy, and long term neurologic
sequelae, the importance reflecting the numbers of
cases, and not so much in the separation of pre- and
postnatal diagnosis. On the basis of this large
population, we conclude that cardiac rhabdomyo-
mas generally regress with time, and that surgical
and/or pharmacological interventions are rarely
required. Arrhythmias exist and may rarely be fatal,
but once adequately treated, they play a minor role
in the overall outcome. The constant association of
cardiac rhabdomyomas with tuberous sclerosis, and
the associated neurological impact, in contrast, is
the dominating aspect in the long-term outcome
and quality of life in these patients. This fact points
to the need for prenatal genetic testing, along with
comprehensive prenatal counselling of parents
whose fetuses are diagnosed with this rare disease.
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